Patent Term at Risk? Navigating OTDP’s Impact on PTA, PTE, and Reissue in Light of Recent Federal Circuit Decisions

Lauren Robinson is a partner in Finnegan, Henderson, Farabow, Garrett & Dunner’s Washington DC office. She is experienced in intellectual property litigation and transactional matters. She focuses on complex patent litigation before U.S. district courts and post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) in a variety of technologies, including the chemical and pharmaceutical fields. In particular, she has extensive district court litigation experience involving energy technologies, catalytic processes, and representing pharmaceutical patent holders in litigations arising under the Hatch-Waxman Act, which governs the approval of pharmaceutical products.